{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:48:58Z","timestamp":1790650138642,"version":"4.1.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K99-DA032681"],"award-info":[{"award-number":["K99-DA032681"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P50-CA143187"],"award-info":[{"award-number":["P50-CA143187"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32-GM008076"],"award-info":[{"award-number":["T32-GM008076"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32-HD046388"],"award-info":[{"award-number":["T32-HD046388"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U19 DA027990"],"award-info":[{"award-number":["U19 DA027990"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.neuropharm.2015.09.012","type":"journal-article","created":{"date-parts":[[2015,9,12]],"date-time":"2015-09-12T15:20:30Z","timestamp":1442071230000},"page":"46-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Anxiolytic- and antidepressant-like effects of the methadone metabolite 2-ethyl-5-methyl-3,3-diphenyl-1-pyrroline (EMDP)"],"prefix":"10.1016","volume":"101","author":[{"given":"Patrick A.","family":"Forcelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill R.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridgin G.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thao T.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxian","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Blendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth J.","family":"Kellar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neuropharm.2015.09.012_bib99","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/FBP.0b013e32832c713e","article-title":"Antidepressant-like effects of nicotine and mecamylamine in the mouse forced swim and tail suspension tests: role of strain, test and sex","volume":"20","author":"Andreasen","year":"2009","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib1","doi-asserted-by":"crossref","first-page":"e48665","DOI":"10.1371\/journal.pone.0048665","article-title":"Low dose nicotine and antagonism of \u03b22 subunit containing nicotinic acetylcholine receptors have similar effects on affective behavior in mice","volume":"7","author":"Anderson","year":"2012","journal-title":"PloS One"},{"issue":"11","key":"10.1016\/j.neuropharm.2015.09.012_bib2","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1111\/bph.13090","article-title":"Anxiolytic-like and anxiogenic-like effects of nicotine are regulated via diverse action at \u03b22*nicotinic acetylcholine receptors","volume":"172","author":"Anderson","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib3","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1517\/14656560903329102","article-title":"Mecamylamine - a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders","volume":"10","author":"Bacher","year":"2009","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib4","first-page":"95","article-title":"Studies on the biochemical and behavioral effects of oral nicotine","volume":"245","author":"Balfour","year":"1980","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.brainres.2007.11.069","article-title":"Nicotine-induced fibroblast growth factor-2 restores the age-related decline of precursor cell proliferation in the subventricular zone of rat brain","volume":"1193","author":"Belluardo","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.31887\/DCNS.2005.7.3\/dbertrand","article-title":"The possible contribution of neuronal nicotinic acetylcholine receptors in depression","volume":"7","author":"Bertrand","year":"2005","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0014-2999(86)90051-8","article-title":"Major tranquillizers can be distinguished from minor tranquillizers on the basis of effects on marble burying and swim-induced grooming in mice","volume":"126","author":"Broekkamp","year":"1986","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib8","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1124\/jpet.108.145292","article-title":"Desensitization of nicotinic acetylcholine receptors as a strategy for drug development","volume":"328","author":"Buccafusco","year":"2009","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"issue":"9","key":"10.1016\/j.neuropharm.2015.09.012_bib100","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.biopsych.2004.08.010","article-title":"High-affinity nicotinic acetylcholine receptors are required for antidepressant effects of amitriptyline on behavior and hippocampal cell proliferation","volume":"56","author":"Caldarone","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.09.012_bib9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00213-011-2271-y","article-title":"Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380","volume":"217","author":"Caldarone","year":"2011","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib10","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.neubiorev.2005.04.017","article-title":"Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on","volume":"29","author":"Carobrez","year":"2005","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0014-2999(91)90433-Q","article-title":"Role of central serotonergic neurons in the effect of sertraline in rats in the forced swimming test","volume":"196","author":"Cervo","year":"1991","journal-title":"Eur. J. Pharmcol"},{"issue":"4","key":"10.1016\/j.neuropharm.2015.09.012_bib12","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1476-5381.1996.tb15232.x","article-title":"Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release","volume":"117","author":"Clark","year":"1996","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2015.09.012_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00213-008-1243-3","article-title":"Endocrine and gene expression changes following forced swim stress exposure during cocaine abstinence in mice","volume":"201","author":"Cleck","year":"2008","journal-title":"Psychopharmacol. Berl. Nov."},{"issue":"8","key":"10.1016\/j.neuropharm.2015.09.012_bib14","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1523\/JNEUROSCI.4804-03.2004","article-title":"Inducible cAMP early repressor regulates corticosterone suppression after tricyclic antidepressant treatment","volume":"24","author":"Conti","year":"2004","journal-title":"J.\u00a0Neurosci."},{"issue":"8","key":"10.1016\/j.neuropharm.2015.09.012_bib15","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1523\/JNEUROSCI.22-08-03262.2002","article-title":"cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs","volume":"22","author":"Conti","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0149-7634(85)90030-2","article-title":"Exploratory behavior models of anxiety in mice","volume":"9","author":"Crawley","year":"1985","journal-title":"Neurosci. Biobehav Rev."},{"issue":"5","key":"10.1016\/j.neuropharm.2015.09.012_bib17","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1067\/mcp.2002.128386","article-title":"Disposition of nasal, intravenous, and oral methadone in healthy volunteers","volume":"72","author":"Dale","year":"2002","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib18","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/nn1580","article-title":"Nicotine addiction and comorbidity with alcohol abuse and mental illness","volume":"8","author":"Dani","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib19","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1126\/science.1222941","article-title":"Depression and hippocampal neurogenesis: a road to remission?","volume":"338","author":"Eisch","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2015.09.012_bib20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s002130000531","article-title":"Antidepressant-like effects of the subtype-selective nicotinic acetylcholine receptor agonist, SIB-1508Y, in the learned helplessness rat model of depression","volume":"152","author":"Ferguson","year":"2000","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib21","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1037\/0735-7044.112.6.1423","article-title":"Bimodal modulation by nicotine of anxiety in the social interaction test: role of the dorsal hippocampus","volume":"112","author":"File","year":"1998","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1369-1600.2007.00078.x","article-title":"Teratogenic effects of maternal antidepressant exposure on neural substrates of drug-seeking behavior in offspring","volume":"13","author":"Forcelli","year":"2008","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib23","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1124\/jpet.111.188862","article-title":"Effects of neonatal antiepileptic drug exposure on cognitive, emotional, and motor function in adult rats","volume":"340","author":"Forcelli","year":"2012","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib24","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/jama.1990.03450120058029","article-title":"Smoking, smoking cessation, and major depression","volume":"264","author":"Glassman","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2015.09.012_bib25","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1046\/j.1471-4159.1994.62041390.x","article-title":"Desensitization of nicotine-stimulated [3H]dopamine release from mouse striatal synaptosomes","volume":"62","author":"Grady","year":"1994","journal-title":"J.\u00a0Neurochem."},{"issue":"3","key":"10.1016\/j.neuropharm.2015.09.012_bib26","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1471-4159.1992.tb08322.x","article-title":"Characterization of nicotinic receptor-mediated [3HDopamine release from synaptosomes prepared from mouse striatum","volume":"59","author":"Grady","year":"1992","journal-title":"J.\u00a0Neurochem."},{"issue":"1","key":"10.1016\/j.neuropharm.2015.09.012_bib27","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1471-4159.2001.00019.x","article-title":"Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum","volume":"76","author":"Grady","year":"2001","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib28","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1471-4159.2005.03126.x","article-title":"Chronic nicotine differentially affects the function of nicotinic receptor subtypes regulating neurotransmitter release","volume":"93","author":"Grilli","year":"2005","journal-title":"J.\u00a0Neurochem."},{"issue":"34","key":"10.1016\/j.neuropharm.2015.09.012_bib29","doi-asserted-by":"crossref","first-page":"13673","DOI":"10.1523\/JNEUROSCI.1669-13.2013","article-title":"Increased hippocampal neurogenesis and accelerated response to antidepressants in mice with specific deletion of CREB in the hippocampus: role of cAMP response-element modulator \u03c4","volume":"33","author":"Gundersen","year":"2013","journal-title":"J.\u00a0Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2015.09.012_bib30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuropharm.2009.04.008","article-title":"Effects of the histone deacetylase inhibitor sodium butyrate in models of depression and anxiety","volume":"57","author":"Gundersen","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.09.012_bib31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0022-3565(25)13322-3","article-title":"Acute effects of nicotine on prolactin release in the rat: agonist and antagonist effects of a single injection of nicotine","volume":"252","author":"Hulihan-Giblin","year":"1990","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib32","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/jnc.12653","article-title":"Chronic sazetidine-A maintains anxiolytic effects and slower weight gain following chronic nicotine without maintaining increased density of nicotinic receptors in rodent brain","volume":"129","author":"Hussmann","year":"2014","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib33","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/ntr\/ntp076","article-title":"Sex differences in response to nicotine in C57Bl\/6:129SvEv mice","volume":"11","author":"Isiegas","year":"2009","journal-title":"Nicotine Tob. Res. Off. J. Soc. Res. Nicotine Tob."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib34","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00006842-197405000-00008","article-title":"Acetylcholine and depression","volume":"36","author":"Janowsky","year":"1974","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib35","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(72)93021-8","article-title":"A\u00a0cholinergic-adrenergic hypothesis of mania and depression","volume":"2","author":"Janowsky","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2015.09.012_bib36","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ajmg.1320540412","article-title":"Is cholinergic sensitivity a genetic marker for the affective disorders?","volume":"54","author":"Janowsky","year":"1994","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib37","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.09.012_bib38","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1046\/j.1471-4159.2001.00357.x","article-title":"Nicotine-evoked transmitter release from synaptosomes: functional association of specific presynaptic acetylcholine receptors and voltage-gated calcium channels","volume":"77","author":"Kulak","year":"2001","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib39","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/479278a","article-title":"Depression drug disappoints","volume":"479","author":"Ledford","year":"2011","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.neuropharm.2015.09.012_bib40","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1523\/JNEUROSCI.13-06-02680.1993","article-title":"Evidene for \u201cpreterminal\u201d nicotinic receptos on GABAergic axons in the rat interpeduncular nucleus","volume":"13","author":"Lena","year":"1993","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib41","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1152\/jn.1995.74.1.195","article-title":"Acetylcholine receptor desensitization induced by nicotine in rat medial habenula neurons","volume":"74","author":"Lester","year":"1995","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib42","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0028-3908(02)00019-9","article-title":"Nicotinic acetylcholine receptor-mediated release of [3H]norepinephrine from developing and adult rat hippocampus: direct and indirect mechanisms","volume":"42","author":"Leslie","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.09.012_bib43","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1755-5949.2008.00054.x","article-title":"TC-5214 (S-(+)-mecamylamine): a neuronal nicotinic receptor modulator with antidepressant activity","volume":"14","author":"Lippiello","year":"2008","journal-title":"CNS Neurosci. Ther."},{"issue":"2","key":"10.1016\/j.neuropharm.2015.09.012_bib44","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0893-133X(99)00100-1","article-title":"Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test","volume":"22","author":"Lopez-Rubalcava","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2015.09.012_bib45","series-title":"Desensitization of Nicotinic Agonist-induced [3H]-\u03b3-aminobutyric Acid Release from Mouse Brain Synaptosomes Is Produced by Subactivating Concentrations of Agonists","author":"Lu","year":"1999"},{"issue":"2","key":"10.1016\/j.neuropharm.2015.09.012_bib46","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0022-3565(24)37839-5","article-title":"Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes","volume":"287","author":"Lu","year":"1998","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib47","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbr.2007.08.036","article-title":"Requirement for the POZ\/BTB protein NAC1 in acute but not chronic psychomotor stimulant response","volume":"187","author":"Mackler","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib48","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1124\/mol.106.027458","article-title":"Heterogeneity of nicotinic cholinergic receptors in rat superior cervical and nodose Ganglia","volume":"70","author":"Mao","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib49","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1046\/j.1471-4159.1994.63062125.x","article-title":"Desensitization of nicotine-stimulated 86Rb+ efflux from mouse brain synaptosomes","volume":"63","author":"Marks","year":"1994","journal-title":"J.\u00a0Neurochem."},{"issue":"5","key":"10.1016\/j.neuropharm.2015.09.012_bib50","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1046\/j.1471-4159.1996.67051974.x","article-title":"Nicotinic autoreceptors mediating enhancement of acetylcholine release become operative in conditions of \u201cimpaired\u201d cholinergic presynaptic function","volume":"67","author":"Marchi","year":"1996","journal-title":"J.\u00a0Neurochem."},{"issue":"1","key":"10.1016\/j.neuropharm.2015.09.012_bib51","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bcp.2014.06.010","article-title":"Presynaptic GABAB autoreceptor regulation of nicotinic acetylcholine receptor mediated [(3)H]-GABA release from mouse synaptosomes","volume":"91","author":"McClure-Bengley","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib52","doi-asserted-by":"crossref","first-page":"10891","DOI":"10.1523\/JNEUROSCI.0937-11.2011","article-title":"\u03b14\u03b22 nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief","volume":"31","author":"McGranahan","year":"2011","journal-title":"J.\u00a0Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib53","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.bcp.2007.07.001","article-title":"Regulation of synaptic transmission and plasticity by neuronal nicotinic acetylcholine receptors","volume":"74","author":"McKay","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib54","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1124\/jpet.108.149609","article-title":"Cytisine-based nicotinic partial agonists as novel antidepressant compounds","volume":"329","author":"Mineur","year":"2009","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib55","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/FBP.0b013e328347546d","article-title":"\u03b14\u03b22 nicotinic acetylcholine receptor partial agonists with low intrinsic efficacy have antidepressant-like properties","volume":"22","author":"Mineur","year":"2011","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib56","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.tips.2010.09.004","article-title":"Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis","volume":"31","author":"Mineur","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib57","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.neuropharm.2007.01.006","article-title":"Cytisine, a partial agonist of high-affinity nicotinic acetylcholine receptors, has antidepressant-like properties in male C57BL\/6J mice","volume":"52","author":"Mineur","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.09.012_bib58","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.neuroscience.2006.12.012","article-title":"Acute intermittent nicotine treatment induces fibroblast growth factor-2 in the subventricular zone of the adult rat brain and enhances neuronal precursor cell proliferation","volume":"145","author":"Mud\u00f2","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.09.012_bib59","series-title":"Guide for the Care and Use of Laboratory Animals","author":"National Research Council (U.S.)","year":"2011"},{"key":"10.1016\/j.neuropharm.2015.09.012_bib60","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.pbb.2013.04.005","article-title":"Potential therapeutic uses of mecamylamine and its stereoisomers","volume":"108","author":"Nickell","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib61","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2006.07.015","article-title":"A\u00a0combined marble burying-locomotor activity test in mice: a practical screening test with sensitivity to different classes of anxiolytics and antidepressants","volume":"547","author":"Nicolas","year":"2006","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2015.09.012_bib62","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/syn.890160105","article-title":"Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area","volume":"16","author":"Nisell","year":"1994","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2015.09.012_bib63","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1476-5381.1991.tb12392.x","article-title":"Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents","volume":"104","author":"Njung'e","year":"1991","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib64","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.mcna.2004.06.007","article-title":"Smoking and depression","volume":"88","author":"Paperwalla","year":"2004","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib65","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1113\/jphysiol.2003.053447","article-title":"Nicotine is highly effective at producing desensitization of rat alpha4beta2 neuronal nicotinic receptors","volume":"553","author":"Paradiso","year":"2003","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib66","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","article-title":"Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat","volume":"14","author":"Pellow","year":"1985","journal-title":"J.\u00a0Neurosci. Methods"},{"issue":"3","key":"10.1016\/j.neuropharm.2015.09.012_bib67","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00213-004-2048-7","article-title":"Forced swimming test in mice: a review of antidepressant activity","volume":"177","author":"Petit-Demouliere","year":"2005","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib68","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/00001756-200207020-00006","article-title":"Effect of nicotine and nicotinic receptors on anxiety and depression","volume":"13","author":"Picciotto","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2015.09.012_bib69","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/37120","article-title":"Nicotine activates and desensitizes midbrain dopamine neurons","volume":"390","author":"Pidoplichko","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.09.012_bib70","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1021\/jm00285a004","article-title":"Synthesis and identification of metabolites resulting from the biotransformation of DL-methadone in man and in the rat","volume":"14","author":"Pohland","year":"1971","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib71","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1901\/jeab.1981.35-31","article-title":"Burying by rats in response to aversive and nonaversive stimuli","volume":"35","author":"Poling","year":"1981","journal-title":"J.\u00a0Exp. Anal. Behav."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib72","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib73","doi-asserted-by":"crossref","DOI":"10.1002\/0471142301.ns0810as14","article-title":"Rodent models of depression: forced swimming and tail suspension behavioral despair tests in rats and mice","author":"Porsolt","year":"2001","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib74","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00213-006-0568-z","article-title":"The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not beta2- or alpha7-nicotinic acetylcholine receptor subunit knockout mice","volume":"189","author":"Rabenstein","year":"2006","journal-title":"Psychopharmacol. Berl."},{"issue":"4","key":"10.1016\/j.neuropharm.2015.09.012_bib75","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1471-4159.1988.tb10582.x","article-title":"Stereoselective nicotine-induced release of dopamine from striatal synaptosomes concentration dependence and repetitive stimulation","volume":"50","author":"Rapier","year":"1988","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib76","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2009.01.002","article-title":"Varenicline has antidepressant-like activity in the forced swim test and augments sertraline's effect","volume":"605","author":"Rollema","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib77","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuropharm.2013.09.021","article-title":"LY2456302 is a novel, potent, orally-bioavailable small molecule kapp-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders","volume":"77","author":"Rorick-Kehn","year":"2014","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.neuropharm.2015.09.012_bib78","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/j.1471-4159.1987.tb01013.x","article-title":"Stimulation of [3H]dopamine release by nicotine in rat nucleus accumbens","volume":"49","author":"Rowell","year":"1987","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib79","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-3565(25)11834-X","article-title":"Bioassay of Rauwolfia roots and alkaloids","volume":"120","author":"Rubin","year":"1957","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib80","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0022-3565(25)24880-7","article-title":"Rapid desensitization of the acute stimulatory effects of nicotine on rat plasma adrenocorticotropin and prolactin","volume":"238","author":"Sharp","year":"1986","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib81","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/da.10035","article-title":"Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine","volume":"16","author":"Shytle","year":"2002","journal-title":"Depress Anxiety"},{"issue":"8","key":"10.1016\/j.neuropharm.2015.09.012_bib82","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1021\/jm00266a009","article-title":"Urinary metabolites of dl-methadone in maintenance subjects","volume":"16","author":"Sullivan","year":"1973","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib83","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00213-009-1466-y","article-title":"Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety","volume":"204","author":"Thomas","year":"2009","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib84","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s002130050879","article-title":"Antidepressant effects of nicotine in an animal model of depression","volume":"142","author":"Tizabi","year":"1999","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib85","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.09.012_bib86","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1124\/jpet.110.166280","article-title":"Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior","volume":"334","author":"Turner","year":"2010","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib87","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/ntr\/ntq206","article-title":"Parallel anxiolytic-like effects and upregulation of neuronal nicotinic acetylcholine receptors following chronic nicotine and varenicline","volume":"13","author":"Turner","year":"2011","journal-title":"Nicotine Tob. Res. Off. J. Soc. Res. Nicotine Tob."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib88","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1038\/npp.2013.105","article-title":"Divergent functional effects of sazetidine-a and varenicline during nicotine withdrawal","volume":"38","author":"Turner","year":"2013","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib89","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00213-013-3195-5","article-title":"Role of kappa-opioid receptors in stress and anxiety-related behavior","volume":"229","author":"Vant Veer","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2015.09.012_bib90","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.neuropharm.2012.06.006","article-title":"Acute behavioural responses to nicotine and nicotine withdrawal syndrome are modified in GABA(B1) knockout mice","volume":"63","author":"Varani","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.09.012_bib91","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pnpbp.2004.08.008","article-title":"Antidepressant effects of nicotine and fluoxetine in an animal model of depression induced by neonatal treatment with clomipramine","volume":"29","author":"V\u00e1zquez-Palacios","year":"2005","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.09.012_bib92","doi-asserted-by":"crossref","first-page":"9438","DOI":"10.1523\/JNEUROSCI.21-23-09438.2001","article-title":"Different requirements for cAMP response element binding protein in positive and negative reinforcing properties of drugs of abuse","volume":"21","author":"Walters","year":"2001","journal-title":"J.\u00a0Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib93","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bbr.2014.09.012","article-title":"Repetitive grooming and sensorimotor abnormalities in an ephrin-A knockout model for autism spectrum Disorders","volume":"278","author":"Wurzman","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib94","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1124\/mol.54.2.322","article-title":"Rat alpha3\/beta4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function","volume":"54","author":"Xiao","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib95","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0022-3565(24)29338-1","article-title":"Blockade of rat alpha3beta4 nicotinic receptor function by methadone, its metabolites, and structural analogs","volume":"299","author":"Xiao","year":"2001","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib96","series-title":"Comparison of Pharmacological Properties of Human versus Rat Alpha4beta2 and Alpha3betat4 Nicotinic Acetylcholine Receptors Stabely Expressed in HEK293 Cells","author":"Xiao","year":"2012"},{"key":"10.1016\/j.neuropharm.2015.09.012_bib97","doi-asserted-by":"crossref","first-page":"9298","DOI":"10.1523\/JNEUROSCI.19-21-09298.1999","article-title":"Multiorgan autonomic dysfunction in mice lacking the \u03b22 and the \u03b24 subunits of neuronal nicotinic acetylcholine receptors","volume":"19","author":"Xu","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.09.012_bib98","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1037\/1064-1297.16.1.66","article-title":"Negative reinforcement\/negative affect reduction cigarette smoking outcome expectancies: incremental validity for anxiety focused on bodily sensations and panic attack symptoms among daily smokers","volume":"16","author":"Zvolensky","year":"2008","journal-title":"Exp. Clin. Psychopharmacol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815301040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815301040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T17:06:59Z","timestamp":1751044019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390815301040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":100,"alternative-id":["S0028390815301040"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.09.012","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anxiolytic- and antidepressant-like effects of the methadone metabolite 2-ethyl-5-methyl-3,3-diphenyl-1-pyrroline (EMDP)","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}